Senolytic drugs

Senolytic start-up gears up for clinical trials

Senolytic drugs

Senescence and the return of established splicing tech

Senolytic drugs

AI to quantify senescent cell counts

A long-awaited Deep-SeSMo AI approach can now be implemented in screening for anti-senescence cell drug candidates.
Senolytic drugs

Juvenescence (1): from strength to strength in R&D and investment firepower

Senolytic drugs

A year in Longevity: progress perspectives

Senolytic drugs

A year in Longevity: founders’ perspectives

Senolytic drugs

Eliminating senescent cells to improve heart attack recovery

Senolytic drugs

NAD boosting to reverse senescence and inflammaging

Senolytic drugs

Silicon Valley is waking up to Longevity and senolytics

Senolytic drugs

Senescence: a new weapon in the fight against cancer

Senolytic drugs

Let’s initiate trials of potential geroprotective therapies

Senolytic drugs

AgelessRx and funding an IRB-approved rapamycin trial

Senolytic drugs

OneSkin launches topical senetherapeutic skin treatment

Senolytic drugs

Big pharma enters senolytic drug discovery programme

Senolytic drugs

Senolytics applied to the rejuvenation of organs

Senolytic drugs

Senolytics research shows Longevity progress

Senolytic drugs

Elysium publishes positive results from two studies for Basis

Senolytic drugs

Taking NAD+ to the next level

Senolytic drugs

UNITY cuts lead program after clinical trial fail

Senolytic drugs

Juvenescence (2): “It’s all about prevention, and that’s incredibly disruptive”

Senolytic drugs

Longevity therapies delivered through skin is a topical issue

Senolytic drugs

SENISCA seeks funding for senescence reversal

Senolytic drugs

Longevity investment: Apollo aims for the moon

Senolytic drugs

Exclusive interview: Professor Richard Faragher and cellular senescence

Senolytic drugs

Re-engineered immune cells are the life and soul of the CAR T

Senolytic drugs

“Avoid the use of DQ as a senolytic therapy”

Senolytic drugs

Classifying aging as a disease – it’s all about the ‘how’

Senolytic drugs

Oisín on aging as a disease and raising $5m seed

Senolytic drugs

Pathway to Longevity: get rid of zombie cells

Senolytic drugs

Exclusive interview: A new generation of senolytic

Senolytic drugs

Senolytic breakthrough brings Longevity one giant leap closer

Senolytic drugs

Professor Lynne Cox talks senescence

Senolytic drugs